Stung by bees 500 times: Utah family says dad needs help recovering
It was a normal morning out in Mexico while on vacation. Richard left his dog, Gretta, in the back of his pickup truck to get breakfast. When he got back, Gretta was surrounded by Africanized bees. Richard wasted no time rushing in to save his best friend.
Some people call the Africanized honey bee 'killer bees.' Insect scientists say they showed up in Utah for the first time in 2008. They are more defensive than European honeybees and can pursue an attacker further and in greater numbers.
'He has worked with bees before; He is a beekeeper. But being attacked by 500 is a different story,' said Stephen Mockabee, Richard's son.
In Richard's case, the attack left him with severe injuries and life-changing complications. Gretta, unfortunately, did not make it.
Stephen said it was a miracle getting his dad back up to the border. He described a chaotic scene with an ambulance, saying 'everyone was running around all over the place.'
'You never see your parents, you know, in a terrible light. It's always in a good, you know, heroic area,' said Stephen. 'But seeing him passed out in the front seat of his truck definitely weighs a lot on me.'
Two months later, Richard is continuing his recovery at a rehabilitation clinic in California. Daily tasks, such as walking and caring for himself, are still a struggle. But one of the hardest things to deal with has been losing Gretta. Stephen told ABC4 that Gretta was everything to his dad.
'It was very hard to tell him as he was trying to recover and actually use his voice and trying to eat again,' said Stephen. 'He was asking where his dog was.'
As Richard continues his recovery, Stephen asks everyone to keep his dad in their thoughts, adding, 'and if you can, just out of the kindness of your heart, with donations, that would be fantastic as well.'
Richard's family established a GoFundMe to help cover his medical expenses and ultimately, bring him home to Lehi. That GoFundMe can be found .
Latest headlines:
Oversight Democrats call for hearing with Epstein victims
Exclusive: Family of 11-year-old drowning victim in Gunnison speaks out, says he was 'not your typical kid'
South Jordan man sentenced to federal prison for CSAM possession, was a repeat offender
Bear Lake Raspberry Days celebrates 40th anniversary
Critical fire threat and high heat today
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
an hour ago
- Associated Press
NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights Progress Across Lead Programs
LOS ANGELES, CA - August 19, 2025 ( NEWMEDIAWIRE ) - NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, reported financial results for the quarter ended June 30, 2025, and provided a corporate update. The Company highlighted progress in all three lead programs, including expanded FDA Fast Track designation for NRX-100 in treating suicidal depression, filing of multiple regulatory documents, and advancement of the NRX-101 NDA. A strategic investor group led by B Group Capital has committed capital through a purchase of restricted common stock with a one-year lockup and no dilutive mechanisms. The capital is expected to support the Company through key regulatory milestones and help scale HOPE Therapeutics and its clinic network. To view the full press release, visit About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. The Company is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression; the company recently filed module 3 manufacturing data to support the New Drug Application for NRX-101. NRx has recently filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner's National Priority Voucher Program for the treatment of suicidal depression. The filing is based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and the Government of France, licensed under a data sharing agreement. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading 'Risk Factors' discussed under the caption 'Item 1A. Risk Factors' in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption 'Item 1A. Risk Factors' in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law.
Yahoo
2 hours ago
- Yahoo
Viking Therapeutics Stock Plunges as Oral Obesity Drug Shows Higher Dropout Rates
Aug 19 - Viking Therapeutics (NASDAQ:VKTX) dropped nearly 40% on Tuesday after reporting results from a mid-stage trial of its experimental oral weight-loss drug, VK2735. The Phase 2 VENTURE-Oral study tested VK2735, a GLP-1/GIP dual receptor agonist, in 280 overweight or obese adults with at least one weight-related condition. Over 13 weeks, patients taking the drug lost up to 12.2% of body weight, while reductions relative to placebo reached 10.9%. Viking said the drug met both primary and secondary endpoints and was generally well tolerated, though 28% of treated patients exited the study compared with 18% on placebo. Warning! GuruFocus has detected 3 Warning Signs with VKTX. Despite meeting its goals, VKTX shares sold off sharply, with investors likely weighing safety signals and high expectations in the competitive obesity drug market. Novo Nordisk (NVO) and Eli Lilly (LLY), major players in GLP-1 therapies, each rose about 1%. Eli Lilly is developing orforglipron, which showed up to 11% weight loss over 72 weeks in a late-stage study. Novo Nordisk has submitted an oral version of semaglutide to the FDA after reporting around 14% weight loss over 64 weeks in Phase 3 testing. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Mom Thought She Just Had Dry Skin. Months Later, She Had Hole 'The Size of a Quarter' in Her Nose After Skin Cancer Diagnosis
Amanda Anderson, 43, received the diagnosis in June after first noticing a "small irritated spot" on her nose in January NEED TO KNOW Amanda Anderson, a mother of four, discovered a small spot on her nose that she thought was dry skin But after several appointments, doctors determined it was actually basal cell carcinoma She underwent surgery to remove the spot and documented her journey online A mother of four thought she just had a bit of dry skin on her nose, months before receiving a shocking diagnosis. Amanda Anderson, 43, from Layton, Utah, first noticed she had a small spot on the side of her nose in January of this year; however, she wasn't initially concerned, as she said her skin often gets dry during the winter months, per SWNS. Anderson ended up getting the spot checked out just to be on the safe side and was given a cream. When the spot came back and started to bleed and scab, Anderson booked another appointment with the doctor, only to be told she didn't have anything to worry about. After having a gut feeling that something was wrong, Anderson went to another medic, who then booked her in for a biopsy in June, before the results came back as basal cell carcinoma on June 23. She was scheduled for surgery three days later to remove the spot. Per the Mayo Clinic, "Basal cell carcinoma is a type of skin cancer. Basal cell carcinoma begins in the basal cells — a type of cell within the skin that produces new skin cells as old ones die off." "Basal cell carcinoma often appears as a slightly transparent bump on the skin, though it can take other forms. Basal cell carcinoma occurs most often on areas of the skin that are exposed to the sun, such as your head and neck," the site adds. Anderson has documented her skin cancer journey on TikTok, writing in the caption of one of her videos, "WEAR YOUR SUNSCREEN!!" "I had a small irritated spot on my nose for 6 months. I finally went into the dermatologist. It wasn't a huge shock to find out it was Basal Cell Carcinoma," she added. "Getting it removed was a HUGE shock. I had no idea what I was getting into!" Anderson wrote, sharing in the clip that she'd had Mohs surgery, and that medics ended up having to do three passes. She wrote over the video per the AP, "It was sooo much bigger than I was expecting," confirming she had 50 plus stitches. The clip featured multiple images showing Anderson's cancer journey, including her having a hole cut from her nose to remove all the cancer cells. The Mayo Clinic describes Mohs surgery as "a procedure used to treat skin cancer," adding, "This surgery involves cutting away thin layers of skin. Each thin layer is looked at closely for signs of cancer. The process keeps going until there are no signs of cancer." "The goal of Mohs surgery is to remove all of the skin cancer without hurting the healthy skin around it. Mohs surgery allows the surgeon to be sure that all the cancer is gone. This makes it more likely that the cancer is cured. It reduces the need for other treatments or more surgery," the site states. Anderson recalled of her initial symptoms, "It was just a little dry spot on the side of my nose," adding, "With it being the winter it's common to have dry patches. I wasn't super concerned at the beginning," per SWNS. Anderson — whose father, Kirk Romney, 66, has also had skin cancer, and has had over 17 Mohs surgeries to remove cancerous cells from his face, neck and shoulders — insisted, "When I noticed the spot at first I wasn't too concerned." "It's typical to get dry patches because of the weather here in Utah," she added. Anderson said of receiving the skin cancer diagnosis, "It's hard to hear. It's on my face and as a woman we do everything we can to make sure our faces look as good as possible." "I'm obsessed about sun cream and shade - I have been my whole life," she added. "So it was a bit of a gut punch." Anderson added of doctors removing part of her nose to get the cancer out, "It was about the size of a quarter. They cut above and below the hole and fold the skin over." Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. Anderson, who continues to keep her followers updated regarding her skin cancer journey on TikTok, confirmed she won't need further treatment, but will have to have check-ups every six months. She said of now wanting to warn others, "The damage is done when you're young. I encourage my daughters to put sun cream on underneath their makeup." "I'm trying to build healthy habits in my kids," Anderson added. "People don't realize you can get sunburnt through the window of a car. We have to take care of our skin like you would your teeth. Skin cancer is so preventable." PEOPLE has reached out to Anderson for an update on her recovery. Read the original article on People Solve the daily Crossword
